'Basket studies' will hold intricate data for cancer drug approvals

Nat Med. 2013 Jun;19(6):655. doi: 10.1038/nm0613-655.
No abstract available

Publication types

  • News

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic*
  • Drug Approval*
  • Humans
  • Indoles / therapeutic use
  • Mutation*
  • Neoplasms / drug therapy
  • Neoplasms / genetics
  • Proto-Oncogene Proteins B-raf / genetics
  • Research Design
  • Sulfonamides / therapeutic use
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf